Mylan Inc. (MYL) Launches Generic Tricor® Tablets
5/17/2013 9:26:50 AM
More...
|
Mylan Inc. (MYL) Launches Generic Zomig® Tablets
5/15/2013 10:05:08 AM
More...
|
Actavis (ACT) Rejects $15 Billion Offer From Mylan Inc. (MYL): Source
5/15/2013 7:04:02 AM
More...
|
Mylan Inc. (MYL) Reports a 19% Increase in First Quarter 2013 Adjusted Diluted EPS to $0.62
5/3/2013 7:17:48 AM
More...
|
Deborah Autor, FDA's Deputy Commissioner for Global Regulatory Operations and Policy, to Join Mylan Inc. (MYL)
5/1/2013 9:35:46 AM
More...
|
Mylan Inc. (MYL) Announces $1 Million Gift to the Pittsburgh Promise Scholarship Fund
4/22/2013 11:14:18 AM
More...
|
Mylan Inc. (MYL) Schedules First Quarter 2013 Financial Results Conference Call and Live Webcast
4/9/2013 6:51:30 AM
More...
|
Mylan Inc. (MYL) Launches Generic Version of Xopenex® Inhalation Solution
3/18/2013 10:42:54 AM
More...
|
Mylan Inc. (MYL) Announces Fortamet® Settlement Agreement
3/14/2013 9:53:06 AM
More...
|
Mylan Inc. (MYL) Files Annual Report on Form 10-K for Year Ended Dec. 31, 2012
3/5/2013 9:30:53 AM
More...
|
|